Skip to content
Disclosery

First Light Asset Management, LLC

Follow

13F filer, CIK 1600004, Edina, MN

First Light Asset Management, LLC reported $1,115,876,336 across 35 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-15. Its ten largest share positions make up 59.87% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001999371-26-010896

Period
2026-03-31
Reported value
$1.12B
Holdings
35
Top 10 weight
59.87%
New
7
Sold out
5

Largest buys vs the previous quarter

SecurityShares changeApprox. value
PVLAadded+271,617$33.9M
APGEadded+291,693$24.6M
TLSInew+5,066,827$20.3M
TECXnew+647,743$20M
OMCLnew+489,846$16.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
IRONexited-523,167-$41.5M
AXGNreduced-1,230,558-$40.8M
MDGLexited-66,831-$38.9M
CNTAreduced-717,949-$28.5M
VERAreduced-555,770-$22.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001999371-26-010896, largest first. % of portfolio is the value over $1,115,876,336, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AXGNAXOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,090,296 shares; 2024Q4: 4,506,795 shares; 2025Q1: 4,474,215 shares; 2025Q2: 4,529,243 shares; 2025Q3: 5,805,730 shares; 2025Q4: 5,233,326 shares; 2026Q1: 4,002,768 shares 4,002,768$133M11.88%-1,230,558Timeline
PVLAPALVELLA THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 541,544 shares; 2025Q4: 709,141 shares; 2026Q1: 980,758 shares 980,758$122M10.96%+271,617Timeline
NEONEOGENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,076,555 shares; 2024Q4: 3,167,585 shares; 2025Q1: 6,042,822 shares; 2025Q2: 6,846,432 shares; 2025Q3: 9,927,269 shares; 2025Q4: 10,035,063 shares; 2026Q1: 9,729,978 shares 9,729,978$72.2M6.47%-305,085Timeline
SIBNSI BONE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,526,215 shares; 2024Q4: 1,136,982 shares; 2025Q1: 1,612,408 shares; 2025Q2: 1,751,001 shares; 2025Q3: 1,917,903 shares; 2025Q4: 5,032,904 shares; 2026Q1: 5,353,190 shares 5,353,190$67.6M6.06%+320,286Timeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 5,940,132 shares; 2024Q4: 5,805,184 shares; 2025Q1: 4,874,124 shares; 2025Q2: 4,293,411 shares; 2025Q3: 3,635,816 shares; 2025Q4: 2,278,940 shares; 2026Q1: 1,560,991 shares 1,560,991$62M5.56%-717,949Timeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 284,991 shares; 2026Q1: 576,684 shares 576,684$48.5M4.35%+291,693Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,355,882 shares; 2025Q4: 3,355,539 shares; 2026Q1: 3,190,645 shares 3,190,645$44.3M3.97%-164,894Timeline
TWSTTWIST BIOSCIENCE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,226,255 shares; 2025Q1: 1,218,699 shares; 2025Q2: 945,033 shares; 2025Q3: 1,194,883 shares; 2025Q4: 1,140,771 shares; 2026Q1: 878,848 shares 878,848$41.8M3.74%-261,923Timeline
CRNXCRINETICS PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 943,611 shares; 2024Q4: 885,453 shares; 2025Q1: 855,419 shares; 2025Q2: 864,136 shares; 2025Q3: 941,516 shares; 2025Q4: 1,194,263 shares; 2026Q1: 1,089,670 shares 1,089,670$39.6M3.55%-104,593Timeline
MASS908 DEVICES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,701,095 shares; 2025Q2: 1,067,613 shares; 2025Q3: 2,510,496 shares; 2025Q4: 4,836,186 shares; 2026Q1: 6,072,563 shares 6,072,563$37.2M3.33%+1,236,377Timeline
NPCENEUROPACE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,584,048 shares; 2025Q2: 1,380,410 shares; 2025Q3: 1,360,071 shares; 2025Q4: 1,349,482 shares; 2026Q1: 2,459,966 shares 2,459,966$32.3M2.9%+1,110,484Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 780,639 shares; 2025Q1: 1,852,290 shares; 2025Q2: 1,714,019 shares; 2025Q3: 1,414,994 shares; 2025Q4: 1,573,701 shares; 2026Q1: 1,001,846 shares 1,001,846$31.6M2.83%-571,855Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 948,131 shares; 2024Q4: 868,882 shares; 2025Q1: 4,633,602 shares; 2025Q2: 3,539,593 shares; 2025Q3: 990,161 shares; 2025Q4: 646,238 shares; 2026Q1: 565,431 shares 565,431$31.4M2.81%-80,807Timeline
SLPSIMULATIONS PLUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 357,157 shares; 2025Q3: 767,760 shares; 2025Q4: 1,968,917 shares; 2026Q1: 2,632,823 shares 2,632,823$31.1M2.79%+663,906Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 648,993 shares; 2024Q4: 309,389 shares; 2025Q1: 271,115 shares; 2025Q2: 128,868 shares; 2025Q3: 280,001 shares; 2025Q4: 294,751 shares; 2026Q1: 280,299 shares 280,299$25.9M2.32%-14,452Timeline
TNDMTANDEM DIABETES CARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,025,307 shares; 2024Q4: 292,117 shares; 2025Q1: 245,257 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,089,493 shares; 2026Q1: 1,314,715 shares 1,314,715$25.2M2.26%+225,222Timeline
ATRCATRICURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,865,536 shares; 2024Q4: 1,969,221 shares; 2025Q1: 1,314,718 shares; 2025Q2: 1,015,170 shares; 2025Q3: 890,362 shares; 2025Q4: 1,175,445 shares; 2026Q1: 729,521 shares 729,521$20.8M1.87%-445,924Timeline
TLSITRISALUS LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,066,827 shares 5,066,827$20.3M1.82%newTimeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 202,393 shares; 2025Q4: not reported; 2026Q1: 647,743 shares 647,743$20M1.79%newTimeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 430,500 shares; 2025Q1: 325,046 shares; 2025Q2: 187,355 shares; 2025Q3: 155,099 shares; 2025Q4: 153,871 shares; 2026Q1: 168,116 shares 168,116$19.8M1.78%+14,245Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 620,811 shares; 2026Q1: 732,860 shares 732,860$17.6M1.58%+112,049Timeline
ESTAESTABLISHMENT LABS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 336,870 shares; 2025Q2: 417,157 shares; 2025Q3: 418,358 shares; 2025Q4: 373,082 shares; 2026Q1: 307,738 shares 307,738$17.5M1.57%-65,344Timeline
HCATHEALTH CATALYST INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,296,490 shares; 2024Q4: 5,241,121 shares; 2025Q1: 10,436,807 shares; 2025Q2: 12,230,181 shares; 2025Q3: 13,436,220 shares; 2025Q4: 12,910,941 shares; 2026Q1: 12,878,700 shares 12,878,700$16.4M1.47%-32,241Timeline
OMCLOMNICELL COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 489,846 shares 489,846$16.4M1.47%newTimeline
KRMDKORU MEDICAL SYSTEMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 5,598,925 shares; 2024Q4: 5,915,434 shares; 2025Q1: 4,454,926 shares; 2025Q2: 4,681,626 shares; 2025Q3: 4,527,737 shares; 2025Q4: 4,210,512 shares; 2026Q1: 3,768,380 shares 3,768,380$16.3M1.46%-442,132Timeline
WGSGENEDX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 242,927 shares 242,927$15.6M1.4%newTimeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,853,851 shares; 2026Q1: 1,843,968 shares 1,843,968$13.4M1.2%-9,883Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 705,234 shares; 2024Q4: 1,261,246 shares; 2025Q1: 1,175,879 shares; 2025Q2: 562,981 shares; 2025Q3: 507,097 shares; 2025Q4: 869,676 shares; 2026Q1: 313,906 shares 313,906$12.6M1.13%-555,770Timeline
MDXGMIMEDX GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 3,343,861 shares; 2025Q1: 3,453,074 shares; 2025Q2: 1,927,494 shares; 2025Q3: 3,652,952 shares; 2025Q4: 3,039,341 shares; 2026Q1: 2,842,892 shares 2,842,892$11.2M1.01%-196,449Timeline
BFLYBUTTERFLY NETWORK INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 3,994,620 shares; 2025Q1: 5,505,649 shares; 2025Q2: 5,465,032 shares; 2025Q3: 1,127,998 shares; 2025Q4: 2,812,131 shares; 2026Q1: 2,660,167 shares 2,660,167$10.7M0.96%-151,964Timeline
SGPSPYGLASS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 375,000 shares 375,000$9.72M0.87%newTimeline
ORGOORGANOGENESIS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 6,777,163 shares; 2025Q3: 7,497,911 shares; 2025Q4: 3,862,820 shares; 2026Q1: 3,498,533 shares 3,498,533$8.29M0.74%-364,287Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 94,420 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 141,784 shares 141,784$8.24M0.74%newTimeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 201,867 shares 201,867$7.91M0.71%newTimeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 180,484 shares; 2025Q4: 295,844 shares; 2026Q1: 87,181 shares 87,181$7.58M0.68%-208,663Timeline

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
IRONDISC MEDICINE INC523,167$41.5Mshares
MDGLMADRIGAL PHARMACEUTICALS INC66,831$38.9Mshares
ABVXABIVAX SA88,674$12Mshares
DYNDYNE THERAPEUTICS INC155,231$3.04Mshares
IWOISHARES TR760$245Kshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001999371-26-010896 base2026-05-15acceptance time not in the bulk data set